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 ABSTRACT 
To determine whether jugular venous reflux (JVR) is associated with cerebral white matter 
changes (WMCs) in individuals with Alzheimer’s disease (AD), we studied 12 AD patients 
24 mild cognitive impairment (MCI) patients and 17 elderly controls age- and sex-matched. 
Duplex ultrasonography and 1.5T MRI scanning was applied to quantify cerebral WMCs [T2 
white matter (WM) lesion and dirty-appearing-white-matter (DAWM)]. Subjects with severe 
JVR had more frequently hypertension (p=0.044), more severe WMC, including increased 
total (p =0.047) and periventricular DAWM volumes (p = 0.008) and a trend for increased 
CSF volumes (p=0.067) compared with the other groups. A significantly decreased (65.8%) 
periventricular DAWM volume (p=0.01) in the JVR positive AD individuals compared with 
their JVR negative counterparts was detected. There was a trend for an increased 
periventricular and subcortical T2 WMC lesion volumes in the JVR positive AD individuals 
compared with their JVR negative counterparts (p=0.073). This phenomenon was not 
observed in either the control or MCI groups. In multiple regression analysis, the increased 
periventricular WMC lesion volume and decreased DAWM volume resulted in 85.7% 
sensitivity and 80% specificity for distinguishing between JVR positive and negative AD 
patients. These JVR-WMC association patterns were not seen in the control and MCI groups. 
Therefore, this pilot study suggests that there may be an association between JVR and WMCs 
in AD patients, implying cerebral venous outflow impairment, might play a role in the 
dynamics of WMCs formation in AD patients, particularly in the periventricular regions. 
Further longitudinal studies are needed to confirm and validate our findings. 
 
Keywords: Alzheimer’s disease, leukoaraiosis, jugular veins, magnetic resonance imaging, 
Doppler ultrasonography 
 Glossary: WM = white matter; WMC = white matter change; ARWMC = age-related white 
matter change; AD = Alzheimer’s disease; MCI = mild cognitive impairment; JVR = jugular 
venous reflux; DAWM = dirty-appearing white matter; LV = lateral ventricle; CSF = 
cerebrospinal fluid. 
 
 INTRODUCTION 
White matter changes (WMCs) with punctate and/or confluent WM lesions in the 
periventricular and/or deep subcortical regions, revealed as hyperintensities on T2-weighted 
or fluid-attenuated inversion recovery (FLAIR) MRI are strongly related to aging [1]. These 
age-related WMCs (ARWMCs) are associated with occurrences of different types of dementia 
including Alzheimer’s disease (AD) and predict faster cognitive decline not only in the 
general population, but also in AD patients [2, 3]. 
 Jugular venous reflux (JVR), characterized by a retrograde flow in internal jugular 
veins (IJVs) during Valsalva maneuvers (VM) or spontaneously at rest, is found more 
frequently in the elderly [4-6]. Recently, it has been found that JVR is associated with 
ARWMC, particularly in posterior brain regions [7]. Retrograde-transmitted venous pressure 
associated with JVR in the elderly is thought to result in accumulated insults to the cerebral 
vasculature, small vessel structure/function, and/or the brain-blood barrier (BBB), leading to 
WM damage [7, 8]. Compared with non-demented individuals, WMCs are more prevalent 
and severe in AD patients [9-14]. In this study, we tested the hypothesis that JVR might be 
involved in the dynamics of WMC formation in AD by evaluating the relationship between 
the severity of JVR and WMC in patients with AD. 
MATERIAL AND METHODS 
Subjects 
Between December 2008 and April 2010, Taiwanese residents consecutively admitted to a 
memory clinic at Taipei Veterans General Hospital, Taiwan due to subjective memory 
complaints were assessed for inclusion. Neurologists performed clinical and neurologic 
evaluations in all participants. A standard set of neuropsychological assessments including the 
Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR) scales were 
used.  
  Subjects eligible for participation in the current study were 55 years of age or older, 
had a CDR score ≤1 (as an assurance that they could cooperate during the VM for JVR 
detection), and were willing to receive brain MRI and neck duplex ultrasonography. 
Exclusion criteria for all subjects were a past history of stroke, ischemic heart disease, 
congestive heart disease, valvular heart disease, cardiac arrhythmia, pulmonary diseases, or 
malignancy, and having brain MRI of insufficient quality for performing quantitative 
volumetric analysis. 
 Vascular risk factors were defined according to international guidelines and 
prospectively identified using all available information including medical charts, laboratory 
results, patient interviews, and neurological examinations (Supplementary  Appendix 1) [15]. 
 Subjects were classified into AD, mild cognitive impairment (MCI) or control groups 
according to the criteria of National Institute of Neurological and Communicative Disorders 
and Stroke/Alzheimer's Disease and Related Disorders Association and by Petersen et al.’s 
study revised by the Stockholm consensus group [16-18]. The hospital’s Institutional Review 
Boards approved the study and each included participant or his/her caregiver provided 
informed consent. 
Color-coded duplex ultrasonography: JVR determination 
Ultrasonographic determination of JVR has been described previously (Supplementary 
Appendix 2) [6, 7]. JVR could be detected spontaneously at rest or only during VM. We 
graded the severity of JVR into three groups: subjects with no JVR on both internal jugular 
vein (IJV) sides were classified as a no-JVR group. Subjects with JVR detected on either or 
both IJV sides during VM only, or subjects with spontaneous JVR on one IJV side and no 
JVR on the other IJV side were graded as the mild-JVR group. Subjects with JVR detected on 
one IJV side spontaneously at rest in combination with JVR detected during VM or 
spontaneously at rest in the other side were graded as the severe-JVR group [7]. 
 MRI acquisition 
All study participants were scanned on 1.5T MRI (Excite II; GE Medical Systems, 
Milwaukee, WI). MRI brain sequences included axial two dimensional (2D) T1- and T2-
weighted imaging (WI), FLAIR and three dimensional (3D) T1 spoiled gradient echo (SPGR) 
pulse sequences. The images were acquired with the following sequence parameters: for 3D 
T1 the repetition time (TR) was 8.5 ms, echo time (TE) 1.8 ms, inversion time (TI) 400 ms, 
flip angle (FA) 15°, slice thickness 1.5mm, field of view (FOV) 260mm x 260mm and matrix 
256 x 256; for T2 the TR was 3700 ms, TE 102 ms, echo train length 19, slice thickness 3mm, 
FOV 240mm x 240mm and  matrix 256 x 256; for FLAIR: TR 9000 ms, TE 120 ms, TI 2250 
ms, slice thickness 3mm, FOV 240mm x 240mm and matrix 256x256.  
MRI image analysis 
The MRI analysis personnel were blinded to the subjects’ demographic and clinical 
characteristics.  
 We classified WMCs as belonging to two groups of signal abnormalities based on 
FLAIR/T2-WI signal intensity: T2 white matter (WM) lesion and dirty-appearing-white-
matter (DAWM). The T2 WM lesion number and volume on T2-WI were outlined using a 
semi-automated edge detection contouring/thresholding technique as described previously 
[19]. Regional localization of WM lesion volume was determined in the periventricular and 
deep subcortical regions. We also outlined areas of DAWM and calculated their number and 
volume. The DAWM was defined as a, non-focal area of signal increase on the FLAIR/T2-
WI, with a subtly increased signal intensity compared with the signal intensity of normal 
appearing WM, as previously proposed [20]. The DAWM showed relatively diffuse border 
compared with focal T2 WM lesions and was tapered off toward the normal appearing WM 
(Fig. 1). The regional localization of DAWM volume was also determined in the 
 periventricular and deep subcortical regions. The data are presented separately for number and 
volume of total and regional T2 WM lesions as well as DAWM. 
 In addition, we used Structural Image Evaluation, using Normalisation, of Atrophy, 
cross-sectional (SIENAX, version 2.6) to estimate normalized lateral ventricular volume 
(NLVV), and normalized CSF volume, as previously described [21]. 
Statistical analysis 
Statistical analysis was undertaken using a combination of Statistical Package for the Social 
Sciences (SPSS, IBM, Armonk, New York, USA) and in-house algorithms written in Matlab 
(Mathworks, Natick, Mass) with the aim of evaluating the impact of JVR on the respective 
MRI variables. 
 Parametric and non-parametric analyses were performed on the respective study 
cohorts to identify significant differences between the various study groups, including disease 
groups, JVR severity score and JVR presence. In order to identify MRI variables that were 
associated with the presence of JVR we obtained plots of the logit vs. logistic function of the 
multiple regression analysis in the respective study groups.  
 Given the exploratory pilot nature of the study, values of p<0.05 were considered 
statistically significant and p<0.1 was considered a trend.  
RESULTS 
Eighty-four subjects [57-93 years of age; mean(SD): 79.77(7.41) years; 33 women; 31 control 
subjects, 33 MCI subjects, and 20 AD subjects] were eligibly enrolled according to our 
criteria. To match age and gender in each disease group, fifty three subjects [64-91 years of 
age; mean(SD): 81.5 (4.50) years; 22 women] of them were enrolled for further analysis. 
There were 17 control subjects, 24 MCI subjects, and 12 AD subjects (Table 1). All the AD 
patients met the diagnostic criteria for AD and CDR=1; and all MCI patients met the 
diagnostic criteria for MCI and had a CDR=0.5. Twenty two subjects (41.5%) had right-sided 
 JVR (all detected during VM) and 23 subjects (43.4%) had left-sided JVR (9 detected 
spontaneously at rest and 14 detected during VM, Table 2). There were 12 subjects (22.6%) 
with bilateral JVR; among them, 5 had unilateral spontaneous JVR at rest with contralateral 
VM-induced JVR and 7 had bilateral VM-induced JVR. Twenty subjects (37.7%) presented 
with JVR on neither side.  
 Table 1 shows the comparisons of clinical characteristics and MRI variables between 
control, MCI and AD groups. From this it can be seen that for all but three study variables 
there was no significant difference between the respective groups. The only exceptions to this 
were: the MMSE score, which was significantly lower in the AD group (p<0.001); the 
number of years in education, which was on average approximately 3 years less in the MCI 
and AD groups (p=0.033); and hyperlipidemia, which had a higher incidence in the AD group 
(p=0.014).    
 The clinical characteristics and MRI variables between the three JVR-graded groups 
are presented in Table 2, which also shows the frequencies of vascular risk factors. The three 
JVR-graded groups were closely age-matched and had similar clinical characteristics, with the 
exception of the incidence of hypertension, which was significantly greater in the mild and 
severe JVR groups (p=0.044). There was a general trend for an increased WMC number and 
volume in the severe-JVR group that reached significance for the total DAWM (p=0.047) and 
periventricular DAWM volume (p=0.008). The more severe JVR group also exhibited a trend 
for increased CSF volumes compared with the other groups (p=0.067).  
 Further investigation, using a 2-tailed Mann Whitney U-test (Table 3), revealed a 
significantly decreased (65.8%) periventricular DAWM volume (p=0.01) in the JVR positive 
AD individuals compared with their JVR negative counterparts. There was also a trend for an 
increased periventricular and subcortical T2 WMC lesion volume in the JVR positive AD 
 individuals compared with their JVR negative counterparts (p=0.073). This phenomenon was 
not observed in the either the control or MCI groups.    
 Figure 2 shows a plot of the logit vs. logistic function of the multiple regression 
analysis for the AD patients group using the periventricular T2 WMC volume (B = 0.0004) 
and  periventricular DAWM volume (B=-0.0039) vs. the JVR positivity score. This resulted 
in sensitivity of 85.7% and specificity of 80% for distinguishing between JVR positive and 
negative AD patients. Similar analysis revealed that none of the MRI variables were 
significantly associated with JVR positivity score in the control and MCI groups. 
DISCUSSION 
The present pilot study was of limited scope, having a small sample size with only few 
subjects who presented with severe JVR. Therefore, our findings should be interpreted with 
caution and no firm conclusions should be made regarding the general applicability of our 
findings at this moment in time. Future studies including larger sample size and more MCI 
and AD patients are needed to confirm the validity of our findings.  
 The principal finding of the present study is that JVR appears to be associated with 
changes in the DAWM, particularly in the periventricular region. Increased DAWM volume, 
particularly in the periventricular region was associated with a more severe JVR score. 
DAWM is defined as a region of intermediate signal intensity between that of T2 WM lesions 
and that of normal-appearing white-matter [20, 23-27]. The measurement of DAWM is 
relatively unexplored territory in neurodegenerative disorders and aging. To the best of our 
knowledge, the present study is the first of its kind to explore measurement of the DAWM in 
elderly. Most of the work on DAWM has been performed in patients with multiple sclerosis 
[20, 23-27], and although the concept of DAWM remains largely under investigation, it 
appears to have potential as a diagnostic metric. Image-pathology correlation studies reveal 
DAWM, compared with T2 WM lesions, to be associated with mild blood brain barrier 
 (BBB) breakdown and myelin loss [20, 23-27]. Therefore, it can be suggested that DAWM 
may represent an earlier stage of WM pathology in elderly [25, 26], which is followed at a 
later stage, by T2 WM lesion formation [35-38]. Indeed, using WMC lesion volumes and 
DAWM it was possible to distinguish between the JVR positive and negative AD patients, 
with high degree of accuracy (sensitivity = 85.7% and specificity = 80%) and minimal 
overlap (Figure 2). These findings suggests that in the AD group, DAWM areas may have 
converted into T2 WM lesions at a greater rate in subjects with more severe JVR (Table 3). 
However, future longitudinal studies are necessary to elucidate the chronological JVR effects 
on WMC formation in AD patients. 
 The present study suggests that periventricular WMCs may be associated with JVR 
(Tables 2 and 3). This regional-association was not shown in our previous study [7], possibly 
because: (1) the volumetric and DAWM approaches used in this study were more sensitive to 
small group differences than the WMC visual-rating scale used previously [20, 22-27]; or (2) 
there were differences in the severe-JVR populations of the groups that were used in the two 
studies [7]. Why the periventricular region in AD patients could be influenced by JVR is 
something unknown at this time. However, there is evidence that venous drainage anomalies 
can influence CSF dynamics, slowing down CSF absorption into the superior sagittal sinus 
[39]. The lateral ventricles represent the major reservoir of CSF in the brain. It has been 
proposed that retrograde-transmitted venous pressure, caused by JVR, may induce venous 
hypertension in the superior sagittal sinus, resulting in decreased CSF absorption and larger 
lateral ventricle volume [28-31] and CSF volume, as evidenced in the present study. 
However, this association has to be further investigated. 
 The etiology of WMC in AD is still uncertain. Our pilot results suggest that DAWM 
may be a precursor to T2 lesion formation and that transition between the two might be 
accelerated by the presence of JVR. It may be that JVR alters the intracranial biomechanics 
 interacting synergistically with other AD pathologies. That these associations were not 
observed in either the MCI subjects or controls may suggest that JVR may play some role in 
late AD pathophysiology. It has been reported that retrogradely transmitted venous 
hypertension in AD patients associated with JVR might: (1) decrease cerebral perfusion, 
damage small vessel structure/function, and possibly damage the BBB [8]; or (2) impair CSF 
absorption, thus reducing CSF net flow, enlarging ventricles, and possibly  lowering β-
amyloid clearance with the result that it accumulates in the periventricular tissues  [32-34]. 
Either one or both of these mechanisms might contribute to WMC formation in AD patients. 
However, at this stage it is not possible to ascertain this, and further investigation is required 
before any causal link between JVR in AD pathology can be claimed. Our findings may serve 
as an important pilot data in this direction.  
 It is noticeable that JVR appears to be associated with certain cardiovascular risk 
factors, e.g. hypertension. Dolic et al. [40] studied 240 healthy individuals and found that the 
presence of heart disease, especially heart murmurs, obesity and cigarette smoking were 
associated with an increased prevalence of extracranial venous abnormalities. These results, in 
addition to the findings from the present study, may imply that cardiovascular or systemic 
metabolic disorders may be involved in the pathophysiology of venous (especially IJV) 
hemodynamic abnormalities. Besides, it is known that patients with hypertension have less 
venous distensibility [41, 42]. One characteristic specific for venous walls is that they have 
greater distensibility than arterial walls which makes them able to accommodate a greater 
range of increased venous pressure [43]. Decreased venous distensibility in hypertension 
might reduce this pressure buffer ability in IJV and repetitive higher venous pressure might 
damage IJV valvular structure and its competence, leading to more frequent JVR seen in 
patients with hypertension.              
  It should be noted that this pilot study had a relatively small sample size and that 
future larger case-control studies are needed to elucidate the differences of WMC severity 
between AD, MCI and control groups. In addition, another limitation of the study is related to 
its cross-sectional nature, and further longitudinal studies are needed to determine temporal 
relationship between JVR and WMC lesion formation in relation to DAWM, particularly in 
the periventricular regions.  
 In conclusion, the findings of our pilot study showed that cerebral venous drainage 
impairment may play some role in the pathophysiology of WMC in the AD patients..  
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 Table 1 Clinical characteristics and MRI variables between control, MCI, and AD groups. 
 
 Control 
(n=17) 
MCI 
(n=24) 
AD 
(n=12) 
p 
Age, years, mean (SD) 81.4 (3.8) 81.4 (4.0) 81.8 (6.4) 0.968 
Females, n (%) 5 (29.4) 11 (45.8) 6 (50.0) 0.457a 
Education, years, mean(SD) 13.4 (1.8) 10.9 (4.4) 9.8 (4.1) 0.033 
MMSE 28.1 (1.6) 26.2 (1.9) 20.4 (3.1) <0.001 
Hypertension, n (%) 11 (64.7) 12 (50.0) 7 (58.3) 0.639a 
Diabetes mellitus, n (%) 4 (23.5) 5 (20.8) 3 (25.0) 0.956a 
Hyperlipidemia, n (%) 3 (17.6) 2 (8.3) 6 (50.0) 0.014a 
Smoking, n (%) 1 (5.9) 1 (4.2) 0 (0.0) 0.709a 
JVR  
Positivec, n (%) 
Severity scored, mean (SD) 
 
11 (64.7) 
1.8 (0.7) 
 
15 (62.5) 
1.9 (0.8) 
 
7 (58.3) 
1.8 (0.8) 
 
0.941a 
0.864b 
WMC number changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
DAWM 
 
28.1 (16.6) 
25.4 (17.3) 
18.2 (21.2) 
 
44.9 (30.6) 
25.3 (16.0) 
33.4 (38.5) 
 
42.6 (18.6) 
24.8 (19.9) 
31.3 (11.6) 
 
0.091 
0.996 
0.246 
WMC volume changes, mean(SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
Subcortical 
Periventricular 
DAWM 
Subcortical 
Periventricular 
 
9.5 (12.8) 
8.6 (12.8) 
2.5 (5.6) 
6.1 (7.8) 
0.9 (0.9) 
0.5 (0.6) 
0.4 (0.4) 
 
11.9 (14.7) 
10.6 (14.7) 
2.2 (3.4) 
8.4 (13.8) 
1.3 (1.1) 
0.7 (0.7) 
0.6 (0.7) 
 
10.6 (16.4) 
9.5 (16.3) 
2.2 (4.2) 
7.4 (12.1) 
1.1 (0.6) 
0.4 (0.3) 
0.7 (0.5) 
 
0.875 
0.909 
0.975 
0.828 
0.483 
0.252 
0.504 
Normalized LV volume 77.4 (27.0) 79.5 (24.8) 91.8 (25.3) 0.294 
CSF volume 374.5 (54.4) 364.0 (63.8) 367.0 (63.4) 0.860 
 
JVR = jugular vein reflux; n = number; SD = standard deviation; % = percentage; WM = 
white matter; WMC = white matter changes; MCI = mild cognitive impairment; AD = 
Alzheimer’s disease; DAWM = dirty-appearing white matter; LV = lateral ventricle; CSF = 
cerebrospinal fluid  
p value determined by one-way ANOVA unless otherwise stated. 
ap value determined using chi square test. 
bp value determined using Kruskal-Wallis test. 
cThe presence of JVR in either side would be defined as JVR positive 
dJVR severity score: 1 = no JVR; 2 = mild JVR; 3 = severe JVR 
 
 
 
 
 
 
 
 
 
 
Table 2. Clinical characteristics and MRI variables between three JVR-graded groups. 
  
 
 No JVR 
(n=20) 
Mild JVR 
(n=28) 
Severe JVR 
(n=5) 
p 
Age, years, mean (SD) 81.1 (3.4) 81.7 (5.0) 81.6 (6.3)  0.882 
Females, n (%) 8 (40.0) 13 (46.4) 1 (20.0) 0.535a 
Disease classification, n (%) 
Control 
MCI 
AD 
 
6 (30.0) 
9 (45.0) 
5 (25.0) 
 
10 (35.7) 
12 (42.9) 
6 (21.4) 
 
1 (20.0) 
3 (60.0) 
1 (20.0) 
0.864b 
Education, years, mean (SD) 12.3 (4.0) 10.9 (3.8) 11.2 (4.2) 0.496 
MMSE 25.1 (4.0) 25.9 (3.1) 24.8 (4.7) 0.705 
Hypertension, n (%) 8 (40.0) 17 (60.7) 5 (100.0) 0.044 a 
Diabetes mellitus, n (%) 7 (35.0) 5 (17.9) 0 (0.0) 0.168 a 
Hyperlipidemia, n (%) 4 (20.0) 6 (21.4) 1 (20.0) 0.992 a 
Smoking, n (%) 0 (0.0) 2 (7.1) 0 (0.0) 0.395 a 
WMC number changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
DAWM 
 
35.4 (20.8) 
23.1 (15.9) 
28.6 (27.4) 
 
38.1 (26.9) 
25.7 (19.1) 
24.3 (32.2) 
 
58.0 (26.6) 
31.0 (3.9) 
46.6 (13.6) 
 
0.193 
0.642 
0.301 
WMC volume changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
Subcortical 
            Periventricular 
DAWM 
Subcortical 
Periventricular 
 
7.3 (8.9) 
6.2 (8.9) 
1.5 (3.2) 
4.7 (7.4) 
1.1 (0.8) 
0.5 (0.4) 
0.7 (0.5) 
 
11.3 (15.2) 
10.4 (15.2) 
2.6 (4.7) 
7.9 (12.6) 
0.9 (1.0) 
0.6 (0.7) 
0.4 (0.4) 
 
21.9 (22.2) 
19.8 (22.6) 
4.1 (6.0) 
15.7 (17.0) 
2.1 (1.0) 
1.0 (0.3) 
1.1 (1.0) 
 
0.119 
0.150 
0.441 
0.159 
0.047 
0.296 
0.008 
Normalized LV volume 81.6 (25.9) 77.8 (24.4) 102.8 (27.4) 0.136 
CSF volume 373.0 (53.0) 355.1 (61.6) 420.7 (53.3) 0.067 
 
JVR = jugular vein reflux; n = number; SD = standard deviation; % - percentage; WM = 
white matter; WMC = white matter changes; MCI = mild cognitive impairment; AD = 
Alzheimer’s disease; DAWM = dirty-appearing white matter; LV = lateral ventricle; CSF = 
cerebrospinal fluid  
Volumes are expressed in millilitres.  
p value determined by one-way ANOVA unless otherwise stated. 
ap value determined using chi square test. 
bp value determined using Kruskal-Wallis test. 
 
 
 
 
 
 
 
 
 
 
Table 3. MRI variables classified according to JVR status (i.e. positive or negative). 
  
 JVR negative JVR positive p 
Controls, n (%) 6 (30.0) 11 (70.0)    NA 
WMC number changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
DAWM 
 
24.2 (16.7) 
21.5 (14.3) 
13.8 (10.3) 
 
30.3 (17.0) 
27.5 (19.1) 
20.5 (25.4) 
 
0.509 
0.713 
0.831 
WMC volume changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
Subcortical 
            Periventricular 
DAWM 
Subcortical 
Periventricular 
 
3.9 (3.4) 
3.3 (3.1) 
0.7 (0.9) 
2.6 (2.5) 
0.6 (0.4) 
0.3 (0.2) 
0.4 (0.3) 
 
12.6 (15.1) 
11.5 (15.2) 
3.5 (6.9) 
8.0 (9.1) 
1.1 (1.1) 
0.6 (0.7) 
0.4 (0.4) 
 
0.216 
0.256 
0.538 
0.216 
0.612 
0.675 
0.904 
Normalized LV volume 69.0 (23.1) 82.0 (28.9) 0.525 
CSF volume 348.0 (49.7) 389.0 (53.4) 0.216 
    
MCI, n (%)  9 (45.0) 15 (55.0)    NA 
WMC number changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
DAWM 
 
35.4 (19.9) 
26.3 (18.2) 
37.9 (37.6) 
 
50.5 (35.0) 
24.7 (15.1) 
30.7 (40.0) 
 
0.633 
0.743 
0.455 
WMC volume changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
Subcortical 
            Periventricular 
DAWM 
Subcortical 
Periventricular 
 
11.4 (12.0) 
10.1 (12.2) 
2.7 (4.6) 
7.4 (10.4) 
1.3 (1.0) 
0.7 (0.6) 
0.6 (0.6) 
 
12.2 (16.4) 
10.9 (16.4) 
2.0 (2.6) 
9.0 (15.7) 
1.3 (1.2) 
0.7 (0.8) 
0.5 (0.8) 
 
0.952 
1.000 
0.905 
0.858 
0.698 
0.952 
0.426 
Normalized LV volume 85.8 (29.6) 75.6 (21.6) 0.474 
CSF volume 377.3 (54.2) 356.0 (69.4) 0.512 
    
AD, n (%) 5 (25.0) 7 (75.0)    NA 
WMC number changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
DAWM 
 
48.8 (22.5) 
19.2 (15.5) 
29.4 (8.6) 
 
38.1 (15.5) 
28.9 (22.7) 
32.6 (13.9) 
 
0.505 
0.530 
0.861 
WMC volume changes, mean (SD) 
T2 WM lesions + DAWM 
T2 WM lesions 
Subcortical 
            Periventricular 
DAWM 
Subcortical 
Periventricular 
 
4.2 (2.2) 
2.8 (1.8) 
0.3 (0.4) 
2.5 (1.6) 
1.4 (0.7) 
0.3 (0.3) 
1.1 (0.4) 
 
15.2 (20.7) 
14.4 (20.4) 
3.5 (5.2) 
10.9 (15.2) 
0.8 (0.5) 
0.4 (0.4) 
0.4 (0.2) 
 
0.202 
0.073 
0.073 
0.073 
0.106 
0.755 
0.010 
Normalized LV volume 88.9 (20.6) 93.8 (29.7) 0.876 
CSF volume 395.4 (53.0) 346.8 (66.2) 0.268 
  
JVR = jugular vein reflux; n = number; SD = standard deviation; % - percentage; WM = 
white matter; WMC = white matter changes; MCI = mild cognitive impairment; AD = 
Alzheimer’s disease; DAWM = dirty-appearing white matter; LV = lateral ventricle; CSF = 
cerebrospinal fluid; NA - non available. 
Volumes are expressed in millilitres.  
p values determined by 2-tailed Mann Whitney U-test. 
 
 
 
 FIGURE LEGENDS 
 
Fig. 1. Examples of periventricular and subcortical white matter T2 lesions and dirty 
appearing white matter in controls,  mild cognitive impairment patients and Alzheimer's 
disease patients. 
 
 
 
 
 
 
 
 
 Fig 2. Plot of the logit vs. logistic function for the AD patients group using the variables 
periventricular T2 WMC volume (B = 0.0004) and  periventricular DAWM volume (B=-
0.0039). Logit = 0.5 is deemed to separate the JVR positive subjects from the negative 
subjects. This results in one false positive and one false negative (sensitivity = 85.7% and 
specificity = 80%). 
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JVR = jugular vein reflux; AD = Alzheimer’s disease; WMC = white matter change; DAWM 
= dirty-appearing white matter 
 SUPPLEMENTARY DATA 
Supplementary Appendix 1: The definitions of vascular risk factors 
Hypertension was defined as a history of hypertension, use of antihypertensive medications, 
or a measured blood pressure consistently >140/90 mm Hg. Hyperlipidemia was defined as a 
cholesterol level >200 mg/dL, low density lipoprotein >150 mg/dL, triglyceride level >150 
mg/dL, or history of hyperlipidemia. Diabetes was defined as a history of diabetes, use of 
medications for diabetes, or an elevated fasting blood glucose >126 mg/dL.  
 
Supplementary Appendix 2: Color-coded duplex ultrasonography: JVR determination 
Neck color-coded duplex sonography was performed in all subjects with a 7-MHz linear 
transducer (iU22; Philips, New York, NY, USA) by the same technician, who was blinded to 
subjects’ characteristics. On examination, subjects were in a head-straight, flat supine position 
after a quiet 10 min rest. The IJV was initially insonated longitudinally and thoroughly from 
the proximal part of the neck base rostrally to the distal part at the submandibular level in 
order to detect any possible spontaneous JVR at baseline. Then, the VM was performed by 
forcible expiration from subject’s mouth into a flexible rubber tube connected to a 
manometer. Subjects were asked to reach 40 mm Hg Valsalva pressure and maintain it for at 
least 10 seconds. During the VM, the distal margin of the window of the color signal was 
placed at the tip of the flow divider of the internal carotid artery. The color box was adjusted 
to include the entire lumen of the IJV; if retrograde color appeared in the center of the lumen, 
the retrograde flow would then be confirmed by Doppler spectrum. JVR was determined 
when the retrograde-flow color in the center of the lumen and the Doppler-flow waveform 
demonstrated reversal of flow for more than 0.5 seconds. 
  
